Chris Froome ‘confident we will get to the bottom’ of adverse analytical finding

Team Sky man takes to Twitter to thank fans for their support

Chris Froome remains confident the reason for his adverse analytical finding in an in-competition anti-doping test at the Vuelta a Espana will be established, after news of the failed test came to light on Wednesday.

Froome’s urine test after stage 18 showed twice the permitted limit of the legal asthma medication Salbutamol, with the Team Sky man admitting he had upped his dosage on the advice of team doctor’s as his asthma got worse.

However, both he and his team insist that he did so within the WADA limits, with Sir Dave Brailsford citing possible physiological reasons for the adverse findings.

Chris Froome says he is confident the reasons for his adverse analytical finding will be established (Pic: Sirotti)

Salbutamol’s performance-enhancing credentials are minimal, but Froome could still face a ban and lose his historic Vuelta a Espana title.

Froome took to Twitter, however, to thank people for their support and to re-iterate his belief that the exact cause of the adverse finding would be revealed.

“Thank you for all the messages of support this morning. I am confident that we will get to the bottom of this.

“Unfortunately I can’t share any more information than I already have until the enquiry is complete.”


Newsletter Terms & Conditions

Please enter your email so we can keep you updated with news, features and the latest offers. If you are not interested you can unsubscribe at any time. We will never sell your data and you'll only get messages from us and our partners whose products and services we think you'll enjoy.

Read our full Privacy Policy as well as Terms & Conditions.